Immunocore Holdings PLC IMCR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 03/05/21 EST
41.00quote price arrow down-0.25 (-0.61%)
Volume
68,534
52 week range
39.02 - 61.99

...

Loading . . .

KEY STATS

  • Open41.34
  • Day High43.57
  • Day Low40.21
  • Prev Close41.25
  • 52 Week High61.99
  • 52 Week High Date02/09/21
  • 52 Week Low39.02
  • 52 Week Low Date02/05/21
  • Market Cap1.768B
  • Shares Out43.13M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-3.38
  • P/E (TTM)-12.12
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-117.834M
  • ROE (MRQ)-
  • Revenue (MRQ)39.37M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-286.48%
  • Debt To Equity (MRQ)218.41%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Immunocore Holdings PLC News

There is no recent news for this security.

Latest IMCR News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Immunocore Holdings plc, formerly Immunocore Holdings Ltd, is a late-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies called Immune mobilizing monoclonal TCRs Against X disease (ImmTAX) designed to treat diseases, including cancer, infectious and autoimmune. The Company is developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced...
Address
90 Park Drive, Milton Park, Abingdon
Abingdon
OX14 4RY
United Kingdom